Wesfarmers has disclosed an expected loss of $60 million this year from its half share of the Covalent Lithium joint venture and a bigger loss next financial year.

Wesfarmers has disclosed an expected loss of $60 million this year from its half share of the Covalent Lithium joint venture and a bigger loss next financial year.